EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy

Margaret Rees; Faustino R Pérez-López; Iuliana Ceasu; Herman Depypere; Tamer Erel; Irene Lambrinoudaki; Karin Schenck-Gustafsson; Tommaso Simoncini; Yvonne van der Schouw; Florence Tremollieres; EMAS

doi:10.1016/j.maturitas.2012.06.009

EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy

Maturitas. 2012 Oct;73(2):171-4. doi: 10.1016/j.maturitas.2012.06.009. Epub 2012 Jul 20.

Authors

Margaret Rees¹, Faustino R Pérez-López, Iuliana Ceasu, Herman Depypere, Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Yvonne van der Schouw, Florence Tremollieres; EMAS

Affiliation

¹ Women's Centre, John Radcliffe Hospital, Oxford, UK.

PMID: 22818886
DOI: 10.1016/j.maturitas.2012.06.009

Abstract

Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the clinical use of vaginal estrogens for this condition focussing on publications since the 2006 Cochrane systematic review. Use after breast cancer, before assessment of cervical cytology and prolapse surgery is also discussed.

Publication types

Practice Guideline

MeSH terms

Atrophy / drug therapy
Estrogens / administration & dosage
Estrogens / therapeutic use*
Female
Humans
Postmenopause*
Vagina / pathology*
Vaginal Diseases / drug therapy*

Substances

Estrogens